NTRB

Nutriband Inc.
CAPPED RATING

Nutriband Inc. (NTRB) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (A); its weakest is Growth (D-). The rating has held at C+ for 4 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
C+
Factor Score 2.7 / 5.0
Growth
D-
Factor Score 1.1 / 5.0
Profitability
C
Factor Score 2.2 / 5.0
Momentum
A
Factor Score 4.2 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -26.0
EV / EBITDA -10.1
Rev Growth YoY -29.7%
Gross Margin 33.1%
Price Return 3M 80.9%
Price Return 12M -2.0%
Catalyst Signal 0.00
Market Cap $72.6M
TTM Revenue $1.6M
Price / Sales 44.9
ROE -100.7%

Historical Factor Score Progression

Held C+ for 4 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 C+ (2.7) D- (1.1) C (2.2) A (4.2) C+ (2.6) C+ (2.6)
2026-11-06 C+ (2.8) D- (1.1) C (2.2) A (4.3) C+ (2.7) C+ (2.6)
2026-10-30 C+ (2.7) D- (1.1) C (2.3) A- (4.1) C+ (2.7) C+ (2.6)
2026-10-23 C+ (2.8) D- (1.1) C (2.2) A- (4.1) C+ (2.6) C+ (2.6)
2026-10-16 C+ (2.7) D- (1.1) C (2.2) A- (3.9) C+ (2.6) C+ (2.5)
Page 1 of 4